Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Colorectal Neoplasms 12Breast Neoplasms 12Pain 11Neoplasms 10Pain, Postoperative 9Prostatic Neoplasms 7Lung Neoplasms 6Agnosia 6Colonic Neoplasms 5Neuralgia 4Keratosis, Actinic 4Cancer Pain 4Liver Neoplasms 3Leiomyoma 3Head and Neck Neoplasms 3Chronic Pain 3Thyroid Neoplasms 2Stomach Neoplasms 2Pilonidal Sinus 2Oropharyngeal Neoplasms 2Neuroma 2Neoplasm Metastasis 2Myofibroma 2Inflammatory Bowel Diseases 2Ileus 2Diverticulitis 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

Nivolumab 146Ipilimumab 137pembrolizumab 122Cyclophosphamide 78Interleukin-2 69aldesleukin 63Temozolomide 46trametinib 37Radiosurgery 37Vemurafenib 36fludarabine 34Biopsy 34dabrafenib 33Radiotherapy 33Blood Specimen Collection 31fludarabine phosphate 30sargramostim 27Bevacizumab 27Introns 23Dacarbazine 22Magnetic Resonance Spectroscopy 21Specimen Handling 20CTLA-4 Antigen 20encorafenib 19cobimetinib 19binimetinib 19Paclitaxel 19Granulocyte-Macrophage Colony-Stimulating Factor 19Cisplatin 17incomplete Freund's adjuvant 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Melanoma × Lidocaine × Clear all
NCT03699995 2026-04-08

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

OHSU Knight Cancer Institute

Phase NA Terminated
17 enrolled
Dermatologic

Melanoma, Nevus, Pigmented

Data powered by HemOnc (CC BY 4.0) Colophon âš¡